Recro Pharma
REPH
$2.09
Share price
-0.48%
Change (1 day)
-28.42%
Change (1 year)
Categories
Market capitalization of Recro Pharma (REPH)
Market cap: $0.12 Billion
As of June 2022 Recro Pharma has a market cap of $0.12 Billion. This makes Recro Pharma the world's 5784th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Recro Pharma from 2014 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.12 B | 54.6% |
| 2021 | $0.07 B | 18.29% |
| 2020 | $0.06 B | -84.23% |
| 2019 | $0.42 B | 176.09% |
| 2018 | $0.15 B | -12.52% |
| 2017 | $0.17 B | 16.31% |
| 2016 | $0.15 B | 83.23% |
| 2015 | $0.08 B | 276.61% |
| 2014 | $0.02 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $479.67 B | 389,143.75% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $2.60 B | 2,017.48% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | $0.45 B | 272.41% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $0.02 B | -78.51% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $0.50 B | 308.35% | 🇺🇸 USA |